190 related articles for article (PubMed ID: 25139337)
1. Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.
Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
Immunogenetics; 2014 Nov; 66(11):663-9. PubMed ID: 25139337
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.
Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
Immunogenetics; 2015 Oct; 67(10):547-61. PubMed ID: 26329766
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
Haralambieva IH; Ovsyannikova IG; Umlauf BJ; Vierkant RA; Shane Pankratz V; Jacobson RM; Poland GA
Vaccine; 2011 Nov; 29(48):8988-97. PubMed ID: 21939710
[TBL] [Abstract][Full Text] [Related]
4. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.
Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
Tissue Antigens; 2008 Sep; 72(3):211-20. PubMed ID: 18715339
[TBL] [Abstract][Full Text] [Related]
5. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
Tischer A; Gerike E
Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
[TBL] [Abstract][Full Text] [Related]
6. 2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.
Haralambieva IH; Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
Hum Immunol; 2010 Apr; 71(4):383-91. PubMed ID: 20079393
[TBL] [Abstract][Full Text] [Related]
7. Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.
White SJ; Haralambieva IH; Ovsyannikova IG; Vierkant RA; O'Byrne MM; Poland GA
Hum Immunol; 2012 Jun; 73(6):636-40. PubMed ID: 22504412
[TBL] [Abstract][Full Text] [Related]
8. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
Haralambieva IH; Ovsyannikova IG; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
Vaccine; 2011 Oct; 29(45):7883-95. PubMed ID: 21875636
[TBL] [Abstract][Full Text] [Related]
9. SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.
Dhiman N; Haralambieva IH; Kennedy RB; Vierkant RA; O'Byrne MM; Ovsyannikova IG; Jacobson RM; Poland GA
Immunogenetics; 2010 Apr; 62(4):197-210. PubMed ID: 20217072
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine.
Ovsyannikova IG; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
Pharmacogenet Genomics; 2012 Jan; 22(1):20-31. PubMed ID: 22082653
[TBL] [Abstract][Full Text] [Related]
11. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
12. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes.
Ovsyannikova IG; Dhiman N; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
Hum Genet; 2010 Feb; 127(2):207-21. PubMed ID: 19902255
[TBL] [Abstract][Full Text] [Related]
13. The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.
Ovsyannikova IG; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
Hum Hered; 2011; 72(3):206-23. PubMed ID: 22086389
[TBL] [Abstract][Full Text] [Related]
14. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.
Umlauf BJ; Haralambieva IH; Ovsyannikova IG; Kennedy RB; Pankratz VS; Jacobson RM; Poland GA
Viral Immunol; 2012 Feb; 25(1):29-36. PubMed ID: 22239234
[TBL] [Abstract][Full Text] [Related]
15. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.
Ovsyannikova IG; Haralambieva IH; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
Hum Genet; 2011 Oct; 130(4):547-61. PubMed ID: 21424379
[TBL] [Abstract][Full Text] [Related]
16. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
[TBL] [Abstract][Full Text] [Related]
17. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226
[TBL] [Abstract][Full Text] [Related]
18. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B
J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859
[TBL] [Abstract][Full Text] [Related]
20. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.
Dhiman N; Ovsyannikova IG; Vierkant RA; Ryan JE; Pankratz VS; Jacobson RM; Poland GA
Vaccine; 2008 Mar; 26(14):1731-6. PubMed ID: 18325643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
